Seelos Therapeutics announced that it has commenced an underwritten public offering of shares of its common stock and accompanying common warrants to purchase shares of its common stock. Titan Partners Group, a division of American Capital Partners, is acting as sole book-running manager for the proposed offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SEEL:
